|
[1]
|
Maisel, A.S., Krishnaswamy, P., Nowak, R.M., et al. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine, 347, 161-167.
http://dx.doi.org/10.1056/NEJMoa020233
|
|
[2]
|
McDonagh, T.A., Robb, S.D., Murdoch, D.R., et al. (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351, 9-13.
http://dx.doi.org/10.1016/S0140-6736(97)03034-1
|
|
[3]
|
Berger, R., Huelsman, M., Strecker, K., et al. (2002) B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation, 105, 2392-2397.
http://dx.doi.org/10.1161/01.CIR.0000016642.15031.34
|
|
[4]
|
Anand, I.S., Fisher, L.D., Chiang, Y.T., et al. (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation, 107, 1278-1283.
http://dx.doi.org/10.1161/01.CIR.0000054164.99881.00
|
|
[5]
|
de Lemos, J.A., Morrow, D.A., Bentley, J.H., et al. (2001) The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. New England Journal of Medicine, 345, 1014-1021.
http://dx.doi.org/10.1056/NEJMoa011053
|
|
[6]
|
Schnabel, R., Lubos, E., Rupprecht, H.J., et al. (2006) B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: Results from the AtheroGene study. Journal of the American College of Cardiology, 47, 552-558.
http://dx.doi.org/10.1016/j.jacc.2005.09.039
|
|
[7]
|
Detaint, D., Messika-Zeitoun, D., Avierinos, J.F., et al. (2005) B-type natriuretic peptide in organic mitral regurgitation: Determinants and impact on outcome. Circulation, 111, 2391-2397.
http://dx.doi.org/10.1161/01.CIR.0000164269.80908.9D
|
|
[8]
|
Li, J. and Wang, L. (2006) B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels, 21, 137-140.
http://dx.doi.org/10.1007/s00380-005-0884-y
|
|
[9]
|
Yamada, T., Murakami, Y., Okada, T., et al. (2007) Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace, 9, 770-774.
http://dx.doi.org/10.1093/europace/eum157
|
|
[10]
|
Chen, L., Wei, T., Zeng, C., et al. (2005) Effect of radiofrequency catheter ablation on plasma B-type natriuretic peptide. Pacing and Clinical Electrophysiology, 28, 200-204.
http://dx.doi.org/10.1111/j.1540-8159.2005.09386.x
|
|
[11]
|
Cakmak, N., Sayar, N., Cakmak, M., et al. (2008) Effects of radiofrequency catheter ablation on myocardial performance index and plasma NT-Pro-BNP levels in patients with Wolff-Parkinson-White syndrome. Echocardiography, 25, 692-698.
http://dx.doi.org/10.1111/j.1540-8175.2008.00669.x
|
|
[12]
|
Kangawa, K. and Matsuo, H. (1984) Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochemical and Biophysical Research Communications, 118, 131-139.
http://dx.doi.org/10.1016/0006-291X(84)91077-5
|
|
[13]
|
Ogawa, Y., Nakao, K., Mukoyama, M., et al. (1991) Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circulation Research, 69, 491-500.
http://dx.doi.org/10.1161/01.RES.69.2.491
|
|
[14]
|
de Zeeuw, D., Janssen, W.M. and de Jong, P.E. (1992) Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney International, 41, 1115-1133.
http://dx.doi.org/10.1038/ki.1992.172
|
|
[15]
|
Yoshimura, M., Yasue, H., Okumura, K., et al. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 87, 464-469.
http://dx.doi.org/10.1161/01.CIR.87.2.464
|
|
[16]
|
Nakagawa, O., Ogawa, Y., Itoh, H., et al. (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an “emergency” cardiac hormone against ventricular overload. Kidney International, 96, 1280-1287.
http://dx.doi.org/10.1172/JCI118162
|
|
[17]
|
Therkelsen, S.K., Groenning, B.A., Kjaer, A., et al. (2008) ANP and BNP in atrial fibrillation before and after cardioversion and their relationship to cardiac volume and function. International Journal of Cardiology, 127, 396-399. http://dx.doi.org/10.1016/j.ijcard.2007.04.059
|
|
[18]
|
Nilsson, B., Goetze, J.P., Chen, X., et al. (2009) Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation. Scandinavian Journal of Clinical & Laboratory Investigation, 69, 843-850.
http://dx.doi.org/10.3109/00365510903318209
|
|
[19]
|
Camm, A.J., Kirchhof, P., Lip, G.Y., et al. (2010) Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace, 12, 1360-1420. http://dx.doi.org/10.1093/europace/euq350
|
|
[20]
|
Gould, P.A., Gula, L.J., Bhayana, V., et al. (2010) Characterization of cardiac brain natriuretic peptide release in patients with paroxysmal atrial fibrillation undergoing left atrial ablation. Circulation: Arrhythmia and Electrophysiology, 3, 18-23.
http://dx.doi.org/10.1161/CIRCEP.108.831586
|